Clinical trials: Prostate Biopsy
Patients With PSA Level 4.0 ng/mL
FFOCT for the Diagnosis of Prostate Cancer
Primary objective : The primary objective is to evaluate the diagnosis performance of FFOCT for cancer detection in patients undergoing TRUS prostate biopsy, as compared to standard pathological evaluation.
- Trial name
- BIOMAGIC 01 (NCT02394223)
- Testing
- Full Field Optical Coherence Tomography (FFOCT) procedure
- Where
- France
- Volunteers
- 91 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Prostate Cancer
ReIMAGINE Prostate Cancer Risk
ReIMAGINE Prostate Cancer Risk is a multi-centre, prospective, observational, longitudinal cohort study of men referred to secondary care with a suspicion of prostate cancer.
- Trial name
- NCT04060589
- Testing
- Tissue donation, Blood Donation, Urine Donation
- Where
- 3 sites in United Kingdom
- Volunteers
- 1,000 people
- Sponsor
- University College, London
Prostate Cancer
Prospective Prolaris Value and Efficacy
This is a prospective study to measure the impact on first-line therapy of genomic testing of biopsy tissue from recently diagnosed treatment-naïve patients with early stage localized prostate cancer.
- Trial name
- P-PROVE (NCT03152448)
- Testing
- Prolaris
- Where
- 12 sites in United States
- Volunteers
- 1,511 people
- Sponsor
- Myriad Genetic Laboratories, Inc.
Prostatic Diseases
Hypnosis Mask: a New Approach to Management of Pain in Medical Imaging
The prostatic biopsies echo-guided are a painful and stressful. The purpose is to test a new medical device created recently, " Hypnos-Pro ", wich uses connected technologies.
- Trial name
- HYPNOTIC (NCT03711643)
- Testing
- Periprostatic nerve block, hypnosis mask
- Where
- France
- Volunteers
- 88 people
- Sponsor
- University Hospital, Lille